Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis

J. Fucikova, E. Becht, K. Iribarren, J. Goc, R. Remark, D. Damotte, M. Alifano, P. Devi, J. Biton, C. Germain, A. Lupo, WH. Fridman, MC. Dieu-Nosjean, G. Kroemer, C. Sautès-Fridman, I. Cremer,

. 2016 ; 76 (7) : 1746-1756. [pub] 20160203

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT14533 MZ0 CEP Register

A high density of tumor-infiltrating mature dendritic cells (DC) and CD8(+) T cells correlates with a positive prognosis in a majority of human cancers. The recruitment of activated lymphocytes to the tumor microenvironment, primed to recognize tumor-associated antigens, can occur in response to immunogenic cell death (ICD) of tumor cells. ICD is characterized by the preapoptotic translocation of calreticulin (CRT) from the endoplasmic reticulum (ER) to the cell surface as a result of an ER stress response accompanied by the phosphorylation of eukaryotic initiation factor 2α (eIF2α). We conducted a retrospective study on two independent cohorts of patients with non-small cell lung cancer (NSCLC) to investigate the prognostic potential of CRT. We report that the level of CRT expression on tumor cells, which correlated with eIF2α phosphorylation, positively influenced the clinical outcome of NSCLC. High CRT expression on tumor cells was associated with a higher density of infiltrating mature DC and effector memory T-cell subsets, suggesting that CRT triggers the activation of adaptive immune responses in the tumor microenvironment. Accordingly, patients with elevated CRT expression and dense intratumoral infiltration by DC or CD8(+) T lymphocytes had the best prognosis. We conclude that CRT expression constitutes a new powerful prognostic biomarker that reflects enhanced local antitumor immune responses in the lung.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014120
003      
CZ-PrNML
005      
20191115111635.0
007      
ta
008      
170413s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1158/0008-5472.CAN-15-1142 $2 doi
035    __
$a (PubMed)26842877
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Fučíková, Jitka, $u Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic. Sotio, Prague, Czech Republic. $d 1983- $7 xx0116819
245    10
$a Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis / $c J. Fucikova, E. Becht, K. Iribarren, J. Goc, R. Remark, D. Damotte, M. Alifano, P. Devi, J. Biton, C. Germain, A. Lupo, WH. Fridman, MC. Dieu-Nosjean, G. Kroemer, C. Sautès-Fridman, I. Cremer,
520    9_
$a A high density of tumor-infiltrating mature dendritic cells (DC) and CD8(+) T cells correlates with a positive prognosis in a majority of human cancers. The recruitment of activated lymphocytes to the tumor microenvironment, primed to recognize tumor-associated antigens, can occur in response to immunogenic cell death (ICD) of tumor cells. ICD is characterized by the preapoptotic translocation of calreticulin (CRT) from the endoplasmic reticulum (ER) to the cell surface as a result of an ER stress response accompanied by the phosphorylation of eukaryotic initiation factor 2α (eIF2α). We conducted a retrospective study on two independent cohorts of patients with non-small cell lung cancer (NSCLC) to investigate the prognostic potential of CRT. We report that the level of CRT expression on tumor cells, which correlated with eIF2α phosphorylation, positively influenced the clinical outcome of NSCLC. High CRT expression on tumor cells was associated with a higher density of infiltrating mature DC and effector memory T-cell subsets, suggesting that CRT triggers the activation of adaptive immune responses in the tumor microenvironment. Accordingly, patients with elevated CRT expression and dense intratumoral infiltration by DC or CD8(+) T lymphocytes had the best prognosis. We conclude that CRT expression constitutes a new powerful prognostic biomarker that reflects enhanced local antitumor immune responses in the lung.
650    _2
$a kalretikulin $x metabolismus $7 D037282
650    _2
$a nemalobuněčný karcinom plic $x metabolismus $x mortalita $7 D002289
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a kohortové studie $7 D015331
650    _2
$a lidé $7 D006801
650    _2
$a nádory plic $x metabolismus $x mortalita $7 D008175
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    _2
$a prospektivní studie $7 D011446
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a T-lymfocyty - podskupiny $x metabolismus $7 D016176
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Becht, Etienne $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
700    1_
$a Iribarren, Kristina $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
700    1_
$a Goc, Jeremy $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
700    1_
$a Remark, Romain $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
700    1_
$a Damotte, Diane $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France. Service d'Anatomie-Pathologique, Hôpital Hotel Dieu, AP-HP, Paris, France.
700    1_
$a Alifano, Marco $u Service de Chirurgie Thoracique, Hôpital Cochin, AP-HP, Paris, France. $7 gn_A_00004243
700    1_
$a Devi, Priyanka $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
700    1_
$a Biton, Jerome $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
700    1_
$a Germain, Claire $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
700    1_
$a Lupo, Audrey $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France. Service d'Anatomie-Pathologique, Hôpital Hotel Dieu, AP-HP, Paris, France.
700    1_
$a Fridman, Wolf Herve $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
700    1_
$a Dieu-Nosjean, Marie-Caroline $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
700    1_
$a Kroemer, Guido $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France. Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France. Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, INSERM UMRS 1138, Paris, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a Sautès-Fridman, Catherine $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France.
700    1_
$a Cremer, Isabelle $u Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS1138, Centre de Recherche des Cordeliers, Paris, France. Université Pierre et Marie Curie-Paris 6, UMRS1138, Paris, France. Université Paris Descartes-Paris 5, UMRS1138, Paris, France. isabelle.cremer@crc.jussieu.fr.
773    0_
$w MED00009437 $t Cancer research $x 1538-7445 $g Roč. 76, č. 7 (2016), s. 1746-1756
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26842877 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20191115111914 $b ABA008
999    __
$a ok $b bmc $g 1200585 $s 974898
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 76 $c 7 $d 1746-1756 $e 20160203 $i 1538-7445 $m Cancer research $n Cancer Res $x MED00009437
GRA    __
$a NT14533 $p MZ0
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...